Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review

Pablo E. Pergola,Roberto Pecoits Filho,Wolfgang C. Winkelmayer,Bruce Spinowitz,Samuel Rochette,Philippe Thompson-Leduc,Patrick Lefebvre,Gigi Shafai,Ana Bozas,Myrlene Sanon,Holly B. Krasa

Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review

2019

Pablo E. Pergola
Roberto Pecoits Filho
Wolfgang C. Winkelmayer
Bruce Spinowitz
Samuel Rochette
Philippe Thompson-Leduc
Patrick Lefebvre
Gigi Shafai
Ana Bozas
Myrlene Sanon
Holly B. Krasa

Background The cost and health-related quality of life (HRQoL) burden associated with treatments for anaemia of chronic kidney disease (CKD) is not well characterized among non-dialysis-dependent (NDD) patients.

Keywords:

Dialysis
Kidney disease
Intensive care medicine
Quality of life
Medicine
Observational study
Cochrane Library
Internal medicine
Randomized controlled trial
MEDLINE
Retrospective cohort study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations